Kano Therapeutics
Pre-clinicalFrom permanent genomic insertion to re-dosable genetic function — KanoDNA is the missing payload layer in cell and gene therapy.
Founded
2020
Focus
Drug Delivery
About
From permanent genomic insertion to re-dosable genetic function — KanoDNA is the missing payload layer in cell and gene therapy.
Funding History
1Total raised: $10M
Seed$10MUndisclosedSep 15, 2021
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile